Atlas Trials

Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

Clinical trial NCT01273662 · COMPLETED

Trial details

NCT number
NCT01273662
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2011-04-01
Primary completion
2016-03-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.